% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Culliford:166716,
author = {R. Culliford and A. J. Cornish and P. J. Law and S. M.
Farrington and K. Palin and M. A. Jenkins and G. Casey and
M. Hoffmeister$^*$ and H. Brenner$^*$ and J.
Chang-Claude$^*$ and I. Kirac and T. Maughan and S. Brezina
and A. Gsur and J. P. Cheadle and L. A. Aaltonen and M. G.
Dunlop and R. S. Houlston},
title = {{L}ack of an association between gallstone disease and
bilirubin levels with risk of colorectal cancer: a
{M}endelian randomisation analysis.},
journal = {British journal of cancer},
volume = {124},
number = {6},
issn = {1532-1827},
address = {Edinburgh},
publisher = {Nature Publ. Group},
reportid = {DKFZ-2021-00063},
pages = {1169-1174},
year = {2021},
note = {2021 Mar;124(6):1169-1174},
abstract = {Epidemiological studies of the relationship between
gallstone disease and circulating levels of bilirubin with
risk of developing colorectal cancer (CRC) have been
inconsistent. To address possible confounding and reverse
causation, we examine the relationship between these
potential risk factors and CRC using Mendelian randomisation
(MR).We used two-sample MR to examine the relationship
between genetic liability to gallstone disease and
circulating levels of bilirubin with CRC in 26,397 patients
and 41,481 controls. We calculated the odds ratio per
genetically predicted SD unit increase in log bilirubin
levels (ORSD) for CRC and tested for a non-zero causal
effect of gallstones on CRC. Sensitivity analysis was
applied to identify violations of estimator assumptions.No
association between either gallstone disease (P value =
0.60) or circulating levels of bilirubin (ORSD = 1.00,
$95\%$ confidence interval (CI) = 0.96-1.03, P value = 0.90)
with CRC was shown.Despite the large scale of this study, we
found no evidence for a causal relationship between either
circulating levels of bilirubin or gallstone disease with
risk of developing CRC. While the magnitude of effect
suggested by some observational studies can confidently be
excluded, we cannot exclude the possibility of smaller
effect sizes and non-linear relationships.},
cin = {C070 / C120 / HD01 / C020},
ddc = {610},
cid = {I:(DE-He78)C070-20160331 / I:(DE-He78)C120-20160331 /
I:(DE-He78)HD01-20160331 / I:(DE-He78)C020-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:33414539},
doi = {10.1038/s41416-020-01211-x},
url = {https://inrepo02.dkfz.de/record/166716},
}